ArticleRSC advances2026

Synergistic NIR-polydopamine nanotherapy for blood-brain barrier crossing and Parkinson's disease intervention.

Xueer Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.